MIC Business Summary

Medical Imaging Corp. (6637.TWO) operates a specialized healthcare services model in Taiwan, primarily generating revenue through three core segments: medical imaging equipment distribution, technical maintenance services, and Medical Imaging Management Services (MIMS). As a primary strategic partner for GE Healthcare in the region, the company facilitates the sale and installation of advanced diagnostic systems, including CT, MRI, and ultrasound, while maintaining a dominant position in the distribution of contrast media such as Omnipaque and Visipaque. Its high-margin MIMS segment employs a "turnkey" outsourcing model, providing hospitals with equipment, technical personnel, and operational management in exchange for recurring service fees or revenue-sharing. Within the Taiwanese market, MIC competes with CHC Healthcare Group (4164.TW), Excelsior Medical (4126.TW), and Transart Medical (6587.TWO), distinguishing itself through its deep integration with GE’s product ecosystem and its focus on regional hospital outsourcing. Founded in 1992 by Chairman Hsieh Chao-Pi, the company is built on over three decades of expertise in medical imaging and strategic international partnerships. As of March 2026, the executive leadership is spearheaded by CEO Sui-Hui Hsieh, who has focused on modernizing the firm’s service offerings through AI-enhanced diagnostic tools and digital health integration. The leadership team maintains a strong pedigree in radiology and medical equipment logistics, supported by a board that includes representatives from major institutional shareholders such as Mingji Investment Co., Ltd. and Zhongguo Investment Co., Ltd. This stable governance structure supports MIC’s long-term strategy of expanding its managed services footprint across Taiwan’s regional healthcare networks.